Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

Amrendra Kumar, Anna E. Vilgelm|Journal for ImmunoTherapy of Cancer|2023

Cited by 21